Infections in Immunocompromised Patients
Infections in Immunocompromised Patients is the most recent release in ACCP's Infectious Diseases Self-Assessment Program (IDSAP). Developed and peer reviewed by expert clinicians, the learning activities published in this book provide the most up-to-date evidence and management strategies for complex infections in immunocompromised patients.
The book offers a total of 16.0 continuing pharmacy education (CPE) hours divided into three modules as follows:
- Module I (4.5 CPE hours)
- Cytomegalovirus
- Candidemia and Invasive Candidiasis
- Module II (6.0 CPE hours)
- Invasive Mold Infections
- Evaluation of Antibiotic Allergies
- The Link Between Stewardship Strategies or Modalities and Antimicrobial Resistance
- Module III (eModule, 5.5 CPE)
- Asymptomatic Bacteriuria (interactive case)
- Nocardia and Atypical Mycobacteria Infections (interactive case)
- Immunization in the Immunocompromised Host (interactive case)
Board Certified Infectious Diseases Pharmacists (BCIDPs) interested in completing the learning activities for specialty recertification credit offered in this IDSAP release must successfully complete the web-based test by November 15, 2021. Clinical pharmacists seeking CPE credit must successfully complete the test by May 17, 2024.
A sample chapter titled “Cytomegalovirus” is available at www.accp.com/docs/bookstore/IDSAP/id2021b1_sample.pdf. More information on the IDSAP series and the current release, Infections in Immunocompromised Patients, is available at www.accp.com/store/product.aspx?pc=IDSAP_2019-2021.